Febrile CrisisConvulStopNCT07335640
Impact of an Information Sheet Given to Parents After an Initial Consultation for a Simple Febrile Seizure at Strasbourg University Hospital
An observational study of Febrile Crisis, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
Simple febrile seizures (SFS) are a very common phenomenon (2-5% of children), mostly without serious consequences for the child or their development, but extremely anxiety-provoking for parents, who develop a "fear of fever" for fear of a recurrence, and request numerous additional tests, not justified according to… Read more about this study
- Who is it for?
- Ages 9 months to 5 years
- Conditions the study is for
- Febrile Crisis
- How many people
- 100 participants
- Where
- 1 siteFrance
- Study dates
- 11 Jun 2025to 11 Jun 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 9 months to 5 years
- All sexes
- No healthy volunteers
- Child
Study population: - Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit)
Who may be able to join
- Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit)
- First visit to the SAUP for a simple febrile seizure
- Meeting the clinical criteria for FCS:
- Generalized seizure lasting less than 15 minutes
- No post-critical deficit
- No recurrence of seizures within 24 hours
Show all 10Show fewer
- No personal history of neurological disorders
- Occurrence between January 1, 2022, and May 1, 2025
- First or second episode of FSFS at the time of consultation
- Presence of one of the two parents during the consultation at the SAUP
Who cannot join
- Patient already seen at the SAUP for FCS
- Child who has already had more than two simple febrile seizures at the time of their visit to the emergency department.
- Child who does not meet the criteria for simple febrile seizures:
- aged less than 9 months or more than 5 years at the time of diagnosis.
- Non-febrile seizure
- Focal seizure
Show all 12Show fewer
- Seizure duration >15 min
- Presence of post-critical deficit
- Multiple seizures within 24 hours
- Personal neurological history.
- Seizure occurring outside the period of interest (January 1, 2022 to May 1, 2025)
- Absence of parents during the SAUP consultation
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service de pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, 67091
Sarah Baer, MD, 33 3 88 12 63 98, sarah.baer@chru-strasbourg.fr
Sarah Baer, MD
About this study
Official title: Impact d'Une Fiche Explicative donnée Aux Parents après Une première Consultation Pour Crise fébrile Simple au Service d'Accueil Des Urgences pédiatriques du CHU de Strasbourg
Simple febrile seizures (SFS) are a very common phenomenon (2-5% of children), mostly without serious consequences for the child or their development, but extremely anxiety-provoking for parents, who develop a "fear of fever" for fear of a recurrence, and request numerous additional tests, not justified according to current guidelines, after a first episode of SFS.
Educating parents about these fever-related crises and fever management, and standardizing the information provided through an explanatory sheet implemented at the SAUP in July 2023, would help reduce consultations for recurrent simple febrile crises, as well as early consultations for isolated fever (reflecting parental anxiety caused by these crises).
- Conditions
- Febrile Crisis
- Keywords
- Febrile crisis, Simple febrile crisis
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of consultations at the Pediatric Emergency Department for recurrent simple febrile crises.
Number of consultations at the Pediatric Emergency Department (SAUP) for recurrent simple febrile crises.
Measured: Up to 4 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jan 2026
- Study start11 Jun 2025
- Primary completionJun 2026 (estimated)
- Study completion11 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Febrile CrisisStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07335640
- Sponsor's protocol ID
- 9695
- Acronym
- ConvulStop
- Status last verified
- Jan 2026
- First submitted
- 2 Jan 2026
- Last updated
- 13 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact d'Une Fiche Explicative donnée Aux Parents après Une première Consultation Pour Crise fébrile Simple au Service d'Accueil Des Urgences pédiatriques du CHU de Strasbourg
- ClinicalTrials.gov ID
- NCT07335640
- Acronym / sponsor ID
- ConvulStop / 9695
- Conditions
- Febrile Crisis
- Keywords
- Febrile crisis, Simple febrile crisis
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 11 Jun 2025 (actual)
- Primary completion
- Jun 2026 (estimated)
- Study completion
- 11 Jun 2026 (estimated)
- First posted
- 13 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Simple febrile seizures (SFS) are a very common phenomenon (2-5% of children), mostly without serious consequences for the child or their development, but extremely anxiety-provoking for parents, who develop a "fear of fever" for fear of a recurrence, and request numerous additional tests, not justified according to current guidelines, after a first episode of SFS.
Educating parents about these fever-related crises and fever management, and standardizing the information provided through an explanatory sheet implemented at the SAUP in July 2023, would help reduce consultations for recurrent simple febrile crises, as well as early consultations for isolated fever (reflecting parental anxiety caused by these crises).
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 9 months to 5 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- - Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit)
Key inclusion criteria (10 listed)
- Child aged between 9 months and 5 years at the time of consultation at the SAUP (emergency pediatric unit)
- First visit to the SAUP for a simple febrile seizure
- Meeting the clinical criteria for FCS:
- Occurrence between January 1, 2022, and May 1, 2025
- First or second episode of FSFS at the time of consultation
Key exclusion criteria (12 listed)
- Patient already seen at the SAUP for FCS
- Child who has already had more than two simple febrile seizures at the time of their visit to the emergency department.
- Child who does not meet the criteria for simple febrile seizures:
- aged less than 9 months or more than 5 years at the time of diagnosis.
- Non-febrile seizure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of consultations at the Pediatric Emergency Department for recurrent simple febrile crises.
Time frame: Up to 4 years
Number of consultations at the Pediatric Emergency Department (SAUP) for recurrent simple febrile crises.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jan 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Febrile Crisis, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sarah Baer, MD (33 3 88 12 63 98, sarah.baer@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of consultations at the Pediatric Emergency Department for recurrent simple febrile crises. (time frame: Up to 4 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2026.